Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADAR: ABC/3TC + Raltegravir vs ABC/3TC + DRV/r in Advanced HIV
NCT01900106Phase 3Completed
- Sponsor
- University of Modena and Reggio Emilia
- Start
- Nov 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by University of Modena and Reggio Emilia. Started Nov 2013; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01900106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900106.